Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Journal of Gastroenterology|March 24, 2007
High polymorphism in the trisomic portion of a gastric cancer cell lineBlake A Jacobson, James M Fink, Bryan A Whitson, et al.
Translational Oncology|May 19, 2020
Blood Outgrowth Endothelial Cells as a Cellular Carrier for Oncolytic Vesicular Stomatitis Virus Expressing Interferon-β in Preclinical Models of Non-Small Cell Lung CancerManish R Patel, Blake A Jacobson, Yan Ji, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 26, 2013
Resistance to EGFR-TKI can be mediated through multiple signaling pathways converging upon cap-dependent translation in EGFR-wild type NSCLCManish R Patel, Joe Jay-Dixon, Ahad A Sadiq, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 30, 2023
Cancer sensitizing effect of deazaflavin analogs is associated with increased intracellular drug accumulationZakia Belhadj, Samuel Offei, Blake A Jacobson, et al.
Cancer Gene Therapy|January 10, 2019
JAK/STAT inhibition with ruxolitinib enhances oncolytic virotherapy in non-small cell lung cancer modelsManish R Patel, Alexander Dash, Blake A Jacobson, et al.
Anticancer Research|September 27, 2015
Targeting Topoisomerase II Activity in NSCLC with 9-Aminoacridine DerivativesDavid M Ferguson, Blake A Jacobson, Joe Jay-Dixon, et al.
The Annals of Thoracic Surgery|August 25, 2006
Effects of insulin-like growth factor-1 receptor inhibition in mesothelioma. Thoracic Surgery Directors Association Resident Research AwardBryan A Whitson, Blake A Jacobson, Sandra Frizelle, et al.
The Annals of Thoracic Surgery|October 30, 2004
ERBB2 amplifications in esophageal adenocarcinomaPeter S Dahlberg, Blake A Jacobson, Ganesh Dahal, et al.
Investigational New Drugs|January 10, 2009
Anti-proliferative effects of simocyclinone D8 (SD8), a novel catalytic inhibitor of topoisomerase IIAhad A Sadiq, Manish R Patel, Blake A Jacobson, et al.
Investigational New Drugs|July 27, 2011
Novel acridine-based agents with topoisomerase II inhibitor activity suppress mesothelioma cell proliferation and induce apoptosisAhmad Raza, Blake A Jacobson, Adam Benoit, et al.
Pageof 3